BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang Y, Guan G, Cheng W, Jiang Y, Shan F, Wu A, Cheng P, Guo Z. ARL2 overexpression inhibits glioma proliferation and tumorigenicity via down-regulating AXL. BMC Cancer 2018;18:599. [PMID: 29843637 DOI: 10.1186/s12885-018-4517-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Jiang Y, Zhao J, Li R, Liu Y, Zhou L, Wang C, Lv C, Gao L, Cui D. CircLRFN5 inhibits the progression of glioblastoma via PRRX2/GCH1 mediated ferroptosis. J Exp Clin Cancer Res 2022;41:307. [PMID: 36266731 DOI: 10.1186/s13046-022-02518-8] [Reference Citation Analysis]
2 Jiang Y, Zhao J, Liu Y, Hu J, Gao L, Wang H, Cui D. CircKPNB1 mediates a positive feedback loop and promotes the malignant phenotypes of GSCs via TNF-α/NF-κB signaling. Cell Death Dis 2022;13:697. [DOI: 10.1038/s41419-022-05149-1] [Reference Citation Analysis]
3 Xu J, Zhang G, Hu J, Li H, Zhao J, Zong S, Guo Z, Jiang Y, Jing Z. UPF1/circRPPH1/ATF3 feedback loop promotes the malignant phenotype and stemness of GSCs. Cell Death Dis 2022;13:645. [DOI: 10.1038/s41419-022-05102-2] [Reference Citation Analysis]
4 Brito C, Costa-Silva B, Barral DC, Pojo M. Unraveling the Relevance of ARL GTPases in Cutaneous Melanoma Prognosis through Integrated Bioinformatics Analysis. Int J Mol Sci 2021;22:9260. [PMID: 34502169 DOI: 10.3390/ijms22179260] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Cao C, He K, Li S, Ge Q, Liu L, Zhang Z, Zhang H, Wang X, Sun X, Ding L. ITPRIP promotes glioma progression by linking MYL9 to DAPK1 inhibition. Cell Signal 2021;85:110062. [PMID: 34111521 DOI: 10.1016/j.cellsig.2021.110062] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Zhang D, Zhao J, Han C, Liu X, Liu J, Yang H. Identification of hub genes related to prognosis in glioma. Biosci Rep 2020;40:BSR20193377. [PMID: 32406502 DOI: 10.1042/BSR20193377] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Xie N, Bai Y, Qiao L, Bai Y, Wu J, Li Y, Jiang M, Xu B, Ni Z, Yuan T, Shi Y, Wu K, Xu F, Wang J, Dong L, Liu N. ARL4C might serve as a prognostic factor and a novel therapeutic target for gastric cancer: bioinformatics analyses and biological experiments. J Cell Mol Med 2021;25:4014-27. [PMID: 33724652 DOI: 10.1111/jcmm.16366] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Pang X, Wang Y, Miao B, Fei S, Chen W. Regulation of ARL2 in colorectal cancer cell proliferation and tumorigenicity, and its negative association with AXL. Oncol Lett 2021;21:196. [PMID: 33574935 DOI: 10.3892/ol.2021.12457] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Vandewalle V, Essaghir A, Bollaert E, Lenglez S, Graux C, Schoemans H, Saussoy P, Michaux L, Valk PJM, Demoulin JB, Havelange V. miR-15a-5p and miR-21-5p contribute to chemoresistance in cytogenetically normal acute myeloid leukaemia by targeting PDCD4, ARL2 and BTG2. J Cell Mol Med 2021;25:575-85. [PMID: 33270982 DOI: 10.1111/jcmm.16110] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
10 Zhu J, Wang L, Zhou Y, Hao J, Wang S, Liu L, Li J. Comprehensive analysis of the relationship between competitive endogenous RNA (ceRNA) networks and tumor infiltrating-cells in hepatocellular carcinoma. J Gastrointest Oncol 2020;11:1381-98. [PMID: 33457008 DOI: 10.21037/jgo-20-555] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
11 Chen L, Zhang X, Wang S, Lin X, Xu L. Circ_0084927 Facilitates Cervical Cancer Development via Sponging miR-142-3p and Upregulating ARL2.Cancer Manag Res. 2020;12:9271-9283. [PMID: 33061617 DOI: 10.2147/CMAR.S263596] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
12 Tan Y, Zhang S, Xiao Q, Wang J, Zhao K, Liu W, Huang K, Tian W, Niu H, Lei T, Shu K. Prognostic significance of ARL9 and its methylation in low-grade glioma. Genomics 2020;112:4808-16. [PMID: 32882327 DOI: 10.1016/j.ygeno.2020.08.035] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 11.5] [Reference Citation Analysis]
13 Casalou C, Ferreira A, Barral DC. The Role of ARF Family Proteins and Their Regulators and Effectors in Cancer Progression: A Therapeutic Perspective. Front Cell Dev Biol 2020;8:217. [PMID: 32426352 DOI: 10.3389/fcell.2020.00217] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 13.5] [Reference Citation Analysis]
14 Zhang J, Zhang Q, Sun C, Huang Y, Zhang J, Wang Q. Clinical relevance of ARF/ARL family genes and oncogenic function of ARL4C in endometrial cancer. Biomed Pharmacother 2020;125:110000. [PMID: 32070877 DOI: 10.1016/j.biopha.2020.110000] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
15 Wang J, Zuo J, Wang MD, Xie WF, Bai XB, Ma XD. Retraction: Receptor tyrosine kinase AXL is correlated with poor prognosis and induces temozolomide resistance in glioblastoma. CNS Neurosci Ther 2020;26:777. [PMID: 31578804 DOI: 10.1111/cns.13227] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
16 Wang Y, Zhao W, Liu X, Guan G, Zhuang M. ARL3 is downregulated and acts as a prognostic biomarker in glioma. J Transl Med 2019;17:210. [PMID: 31234870 DOI: 10.1186/s12967-019-1914-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
17 Jiang Y, Zhou J, Hou D, Luo P, Gao H, Ma Y, Chen YS, Li L, Zou D, Zhang H, Zhang Y, Jing Z. Prosaposin is a biomarker of mesenchymal glioblastoma and regulates mesenchymal transition through the TGF-β1/Smad signaling pathway. J Pathol 2019;249:26-38. [PMID: 30953361 DOI: 10.1002/path.5278] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
18 Tong H, Zhao K, Zhang J, Zhu J, Xiao J. YB-1 modulates the drug resistance of glioma cells by activation of MDM2/p53 pathway. Drug Des Devel Ther 2019;13:317-26. [PMID: 30679904 DOI: 10.2147/DDDT.S185514] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
19 Jiang Y, Zhou J, Luo P, Gao H, Ma Y, Chen YS, Li L, Zou D, Zhang Y, Jing Z. Prosaposin promotes the proliferation and tumorigenesis of glioma through toll-like receptor 4 (TLR4)-mediated NF-κB signaling pathway. EBioMedicine 2018;37:78-90. [PMID: 30385233 DOI: 10.1016/j.ebiom.2018.10.053] [Cited by in Crossref: 34] [Cited by in F6Publishing: 40] [Article Influence: 8.5] [Reference Citation Analysis]